APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

“So, we need to increase efficiency on the process development side. While automation is one way of doing that, a much more efficient solution is to use in silico process development data to increase ...

Luckily, the hiring process proceeded smoothly and Charles van Zyl joined as chief executive from Belgian pharma company UCB ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

"Delphine's breadth of pharmaceutical development experience ... the risks inherent in the drug development process, the risks regarding the accuracy of our estimates of expenses and timing of ...

"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.